<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-23T14:41:06Z</responseDate><request verb="GetRecord" identifier="oai:www.repository.cam.ac.uk:1810/389081" metadataPrefix="uketd_dc">https://api.repository.cam.ac.uk/server/oai/request</request><GetRecord><record><header><identifier>oai:www.repository.cam.ac.uk:1810/389081</identifier><datestamp>2025-12-20T03:24:35Z</datestamp><setSpec>com_1810_245310</setSpec><setSpec>com_1810_256062</setSpec><setSpec>col_1810_245312</setSpec></header><metadata><uketd_dc:uketddc xmlns:uketd_dc="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:uketdterms="http://naca.central.cranfield.ac.uk/ethos-oai/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/ http://naca.central.cranfield.ac.uk/ethos-oai/2.0/uketd_dc.xsd">
   <dc:title>Psychosocial Impact of Paediatric Early Rapid Genomic Testing and Diagnosis: A Mixed Methods Study of Parental Adjustment, Adaptation, Risk and Resilience</dc:title>
   <dc:identifier xsi:type="dcterms:DOI">https://doi.org/10.17863/CAM.121146</dc:identifier>
   <dc:creator>Dolling, Helen</dc:creator>
   <uketdterms:authoridentifier xsi:type="uketdterms:ORCID">0000000162793622</uketdterms:authoridentifier>
   <uketdterms:advisor>Hughes, Claire</uketdterms:advisor>
   <uketdterms:advisor>O'Curry, Sara</uketdterms:advisor>
   <uketdterms:advisor>Baker, Kate</uketdterms:advisor>
   <dcterms:abstract>Technological advances have expanded the availability of genome sequencing in Paediatrics, 
with infants and children in intensive care units being eligible for rapid trio testing (rWGS). 
In the UK, the Next Generation Children Project (NGC; French et al., 2019, 2022) was the 
first large cohort of infants and children (521 families) to have received rapid trio WGS
analysis for any suspected single gene disorder during their time in an Intensive Care Unit or 
under tertiary clinics. This Peregrin* study follows up mothers and fathers from the NGC 
project and applies a mixed methods approach to explore their perspectives on the 
psychosocial impact of rWGS, including potential benefits and harms, personal utility, 
decisional regret, and support needs. A secondary aim was to identify risk and protective 
factors for family adjustment and adaptation. 
Participants included 96 parents from 63 families, of whom 58% had received a molecular 
diagnosis of mostly rare or ultra-rare disease in their child. Validated online questionnaires
were completed by fathers and mothers, who reported on demographic variables, family 
impact, child’s quality of life, and parent wellbeing. 91 parents completed semi-structured 
individual Zoom-based interviews, which were analysed by framework and deductive and 
inductive content analysis methods (Forman &amp; Damschroder, 2007; Gale et al., 2013; 
Kyngäs, 2020). Questionnaire data were compared with population norms, between parents
of children with/without a molecular diagnosis and between mothers and fathers within
couples. To consider effects of diagnosis and parent gender on parent and family wellbeing,
IBM SPSS Statistics was used for descriptive statistics, correlations, and linear regression
analyses.
Both negative and positive rWGS results were viewed by parents as worthwhile and helpful
in facilitating adjustment, adaptation, and long-term decision-making. Parents reported
multiple benefits relating to personal utility, beyond their child’s medical management, 
including reproductive autonomy, enhanced coping, mental preparation, and behavioural and 
social benefits, expressed low decisional regret or harm from rWGS, and endorsed early 
testing. However, many parents also reported feeling anxious and/or uncertain about the
future. Overall, 25.3% of parents (36% in the diagnosed group) reported insufficient support
and unmet needs. Condition-specific support groups were helpful to many, but parents’
engagement, information needs, and ability to cope with diagnosis and prognosis varied.
Families undergoing early genomic sequencing require holistic family support pre- and post testing and across the child’s illness trajector</dcterms:abstract>
   <uketdterms:institution>University of Cambridge</uketdterms:institution>
   <dcterms:issued>2025-01-02</dcterms:issued>
   <dc:type>Thesis</dc:type>
   <uketdterms:qualificationlevel>Doctoral</uketdterms:qualificationlevel>
   <uketdterms:qualificationname>Doctor of Philosophy (PhD)</uketdterms:qualificationname>
   <dc:language>eng</dc:language>
   <uketdterms:sponsor>NIHR Cambridge BRC, Rosetrees Trust, Isaac Newton Trust, Cambridge Reproduction SRI</uketdterms:sponsor>
   <dcterms:isReferencedBy xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/handle/1810/389081</dcterms:isReferencedBy>
   <dc:identifier xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/bitstreams/e597df20-3d93-4c31-b95d-865686182ba2/download</dc:identifier>
   <uketdterms:checksum xsi:type="uketdterms:MD5">067d21bdd23e78e67901b3d302e810cd</uketdterms:checksum>
   <dcterms:license>https://www.repository.cam.ac.uk/bitstreams/70dcde1e-5ce4-4dce-81aa-e4c4586623de/download</dcterms:license>
   <uketdterms:checksum xsi:type="uketdterms:MD5">87eda9de84448d1f82354d60eee3eb5f</uketdterms:checksum>
   <dc:rights>http://purl.org/NET/rdflicense/allrightsreserved</dc:rights>
   <dc:subject>NICU</dc:subject>
   <dc:subject>PICU</dc:subject>
   <dc:subject>rapid genome sequencing</dc:subject>
   <dc:subject>support</dc:subject>
   <dc:subject>psychosocial impact</dc:subject>
   <dc:subject>parents of infants and children with complex health conditions</dc:subject>
</uketd_dc:uketddc>
</metadata></record></GetRecord></OAI-PMH>